Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

41,509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rare tumors: a blue ocean of investigation.
Wang S, Ma P, Jiang N, Jiang Y, Yu Y, Fang Y, Miao H, Huang H, Tang Q, Cui D, Fang H, Zhang H, Fan Q, Wang Y, Liu G, Yu Z, Lei Q, Li N. Wang S, et al. Among authors: yu y, yu z. Front Med. 2023 Apr;17(2):220-230. doi: 10.1007/s11684-023-0984-z. Epub 2023 Apr 26. Front Med. 2023. PMID: 37185946 Review.
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges.
Huang H, Tang Y, Yu Y, Yu A, Wu D, Fang H, Wang S, Sun C, Wang X, Fan Q, Fang Y, Tang Q, Jiang N, Du J, Miao H, Bai Y, Ma P, Xing S, Cui D, Miao S, Jiang Y, Zhu J, Zhu Q, Leng Y, Guo LW, Liao S, Shao Y, Song Y, Liu Z, Hong M, Luo S, Xu B, Lan G, Li N. Huang H, et al. Among authors: yu a, yu y. Lancet Reg Health West Pac. 2022 Nov 18;31:100624. doi: 10.1016/j.lanwpc.2022.100624. eCollection 2023 Feb. Lancet Reg Health West Pac. 2022. PMID: 36426285 Free PMC article. Review.
Targeting rare tumors: new focus for clinical research in China.
Wang S, Jiang Y, Miao H, Fang Y, Jiang N, Yu Y, Ma P, Tang Q, Cui D, Fang H, Huang H, Fan Q, Sun C, Yu A, Miao S, Du J, Zhu J, Wang Y, Li N. Wang S, et al. Among authors: yu a, yu y. EMBO Mol Med. 2023 Jan 11;15(1):e16415. doi: 10.15252/emmm.202216415. Epub 2022 Nov 28. EMBO Mol Med. 2023. PMID: 36437781 Free PMC article.
Outcome measures of phase III anticancer drug trials in China.
Guo L, Huang H, Yu Y, Wang J, Wang L, Wang S, Wu D, Fang Y, Jiang N, Zhang S, Tang Y, Li N. Guo L, et al. Among authors: yu y. Chin Med J (Engl). 2023 Apr 20;136(8):992-994. doi: 10.1097/CM9.0000000000002264. Epub 2023 Apr 7. Chin Med J (Engl). 2023. PMID: 37026851 Free PMC article. No abstract available.
Unveiling quality of clinical trial in China: from concern to confirmation.
Huang H, Hou Y, Fang H, Xu L, Yu Y, Zhang H, Zhang J, Tang Y, Lan G, Zhang W, Li N. Huang H, et al. Among authors: yu y. Cancer Commun (Lond). 2024 May;44(5):576-579. doi: 10.1002/cac2.12528. Epub 2024 Mar 6. Cancer Commun (Lond). 2024. PMID: 38446523 Free PMC article. No abstract available.
Exosome-based anticancer vaccines: From Bench to bedside.
Zhao G, Wang Y, Xing S, Jiang Y, Ding J, Cai Y, Ma P, Miao H, Fang Y, Jiang N, Cui D, Yu Y, Tang Q, Wang S, Li N. Zhao G, et al. Among authors: yu y. Cancer Lett. 2024 Jul 28;595:216989. doi: 10.1016/j.canlet.2024.216989. Epub 2024 May 31. Cancer Lett. 2024. PMID: 38825162 Review.
Growing research and development of targeted anticancer drugs in China.
Huang H, Du J, Meng X, Wu D, Yu Y, Wang S, Wang L, Wang W, Tang Y, Li N. Huang H, et al. Among authors: yu y. J Natl Cancer Cent. 2023 Apr 19;3(2):129-134. doi: 10.1016/j.jncc.2023.02.004. eCollection 2023 Jun. J Natl Cancer Cent. 2023. PMID: 39035724 Free PMC article.
Stakeholder Network Analysis for Front-of-Pack Labeling in China.
Yin X, Ye L, Xin X, Xiang L, Yu Y, Yan R, Wen K, Tian M, Jones A, Pettigrew S, Zhang J. Yin X, et al. Among authors: yu y. Front Nutr. 2022 May 23;9:871062. doi: 10.3389/fnut.2022.871062. eCollection 2022. Front Nutr. 2022. PMID: 35677544 Free PMC article.
41,509 results
You have reached the last available page of results. Please see the User Guide for more information.